[ET Net News Agency, 17 July 2025] 3SBIO (01530) rose 10% to HK$30.75.
It hits an intra-day high of HK$30.75, hitting a historical high, and an intra-day low of HK$28.05. The total shares traded was 42.27 million, with a value of HK$1.27b. The active buy/sell ratio is 68:32, with net buying turnover of HK$436.4m. CLSA LTD accounts for greatest net responsive buying turnover of HK$12.53m, with volume weighted average price of HK$29.959. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$91.55m, with volume weighted average price of HK$29.945.
Basic Information| Nominal | 30.750 | % Chg | +10.02% |
| High | 30.750 | Low | 28.050 |
| Shares Tr | 42.27m | Turnover | 1.27b |
| 10-D SMA | 26.440 | %H.V | 54.452 |
| 20-D SMA | 24.535 | VWAP | 29.958 |
| 50-D SMA | 20.839 | RSI14 | 77.937 |
Status: Hitting a historical high, active buy/sell ratio is 68:32, with net buying turnover of HK$436.4m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| 3SBIO (01530) | 30.75 | +10.02 |
| SINO BIOPHARM (01177) | 6.71 | +4.19 |
| EVEREST MED (01952) | 72.50 | +0.14 |
| KEYMED BIO-B (02162) | 56.85 | +13.70 |
| WUXI XDC (02268) | 50.45 | +3.38 |
| ASCENTAGE-B (06855) | 77.85 | +5.42 |
| SKB BIO-B (06990) | 385.40 | +8.44 |
| ZAI LAB (09688) | 29.00 | +4.50 |
| AKESO (09926) | 140.60 | +11.59 |
| REMEGEN (09995) | 69.35 | +1.09 |
(ed)
